Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Otolaryngol Head Neck Surg. 2019 Mar 12;161(1):105–110. doi: 10.1177/0194599819835534

Table 2.

Risk Factors for Body Image Disturbance (Body Image Scale Score ≥10) at 1 Month Postoperatively and 3 Months Posttreatment.a

BIS Score ≥10 at 1 Month Postoperatively
BIS Score ≥10 at 3 Months Posttreatment
Characteristic nb Unadjusted OR (95% CI) Adjustedc OR (95% CI) nb Unadjusted OR (95% CI) Adjustedc OR (95% CI)
Sex 51 49
 Male Reference Reference Reference Reference
 Female 2.25 (0.59–8.7) 2.20 (0.48–10.6) 4.8 (1.3–19.8) 4.3 (0.88–23.9)
Age, y 51 49
 40+ Reference Reference Reference Reference
 <40 7.6 (0.66–173.7) 4.9 (0.24–142.7) 6.4 (0.56–144.9) 3.9 (0.15–124.4)
Marital status 51 49
 Married/current partner Reference Reference Reference Reference
 Single, divorced, separated, widowed 0.43 (0.09–1.7) 0.32 (0.04–1.6) 0.38 (0.07–1.5) 0.23 (0.03–1.3)
BMI 51 49
 Overweight or obese Reference Reference Reference Reference
 Underweight or normal 1.6 (0.41–6.1). 1.9 (0.39–9.5) 0.68 (0.13–2.8) 0.99 (0.16–5.1)
AJCC Pathologic T Classification 51 49
 0, 1, or 2 Reference Reference Reference Reference
 3 or 4a 8.9 (2.0–63.7) 19.6 (2.8–352.3) 3.15 (0.85–13.5) 3.8 (0.8–24.2)
Reconstructive surgery 51 49
 None or dermal Reference Reference Reference Reference
 Substitute rotational flap 4.7 (0.16–144.5) 11.1 (0.25–832.8) 1.8 (0.07–27.2) 1.3 (0.04–23.2)
 Microvascular free flap 6.4 (1.0–123.3) 21.5 (1.7–1341.8) 2.5 (0.54–18.1) 2.3 (0.39–20.8)
Osseous microvascular free flap reconstruction 51 49
 No Reference Reference Reference Reference
 Yes 2.9 (0.50–15.7) 22.3 (2.4–304.5) 1.1 (0.15–6.1) 4.7 (0.49–42.4)
Pretreatment Shame and Stigma Scale 50 1.06 (1.01–1.13) 1.06 (0.19–6.07) 48 1.11 (1.04–1.21) 1.02 (0.91–1.15)
Pretreatment PROMIS Emotional Distress–Anxiety SF4a 50 1.15 (0.98–1.39) 1.00 (0.80–1.25) 48 1.19 (1.00–1.46) 0.98 (0.75–1.26)
Pretreatment PROMIS Emotional Distress–Depression SF4a 50 1.25 (1.06–1.51) 1.08 (0.85–1.36) 48 1.13 (0.96–1.34) 0.80 (0.54–1.07)
Pretreatment PROMIS Satisfaction with Social Roles and Activities SF4a 51 0.88 (0.77–0.98) 0.94 (0.82–1.10) 49 0.90 (0.79–1.01) 0.98 (0.84–1.15)
Pretreatment PROMIS Social Isolation SF4a 51 1.21 (1.01–1.49) 1.05 (0.79–1.34) 49 1.13 (0.92–1.39) 0.88 (0.58–1.18)
Pretreatment Performance Status– Head and Neck, average across subscales 50 0.98 (0.95–1.02) 1.00 (0.97–1.05) 48 0.97 (0.94–1.00) 0.98 (0.95–1.02)
Performance Status Scale–Head and Neck, Normalcy of Diet 50 48
 90, 100 Reference Reference Reference Reference
 0, 10, …, 80 1.09 (0.21–4.65) 0.79 (0.11–4.31) 2.11 (0.52–8.34) 2.75 (0.46–17.14)
Performance Status Scale–Head and Neck, Public Eating 50 48
 75, 100 Reference Reference Reference Reference
 0, 25, 50 2.06 (0.37–9.81) 1.00 (0.12–6.14) 1.45 (0.27–6.67) 0.86 (0.10–5.35)
Performance Status Scale–Head and Neck, Understandability of Speech 51 49
 75, 100 Reference Reference Reference Reference
 0, 25, 50 2.27 (0.40–11.18) 1.22 (0.12–8.35) 2.76 (0.58–12.73) 1.78 (0.23–11.49)

Abbreviations: AJCC, American Joint Committee on Cancer; BIS, Body Image Scale; BMI, body mass index; CI, confidence interval; OR, odds ratio.

a

Bold values are statistically significant.

b

N < 56 for certain patient-reported outcome measures (PROMs; PROMs were treated as missing if any individual question for that instrument was missing).

c

Adjusted for pretreatment Body Image Scale scores (treated as a continuous variable) using multiple logistic regression models.